Abbott's Omnilink Elite® Vascular Balloon ... | 合法醫療器材資訊網

2012年8月7日—ABBOTTPARK,Ill.,Aug.7,2012/PRNewswire/--AbbotttodayannouncedthattheU.S.FoodandDrugAdministration(FDA)approvedtheOmnilink ...

ABBOTT PARK, Ill., Aug. 7, 2012 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite® Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) that affects the lower extremities. Iliac artery disease can progress to where patients experience chronic pain and reduced ability to walk, potentially leading to permanent disability. The FDA approval is supported by positive clinical data from the MOBILITY (Omnilink Elite or Absolute Pro® Stent Used in the Iliac Artery) study. The MOBILITY study demonstrated that Omnilink Elite is safe and effective, including when used for patients who are difficult-to-treat due to complex disease resulting from severely calcified lesions. 

The Omnilink Elite stent is based on the proven, market-leading MULTI-LINK stent desig...